Cargando…
Umbilical Cord-Derived Mesenchymal Stem Cells for Hematopoietic Stem Cell Transplantation
Hematopoietic stem cell transplantation (HSCT) is becoming an effective therapeutic modality for a variety of diseases. Mesenchymal stem cells (MSCs) can be used to enhance hematopoietic engraftment, accelerate lymphocyte recovery, reduce the risk of graft failure, prevent and treat graft-versus-hos...
Autores principales: | Chao, Yu-Hua, Wu, Han-Ping, Chan, Chin-Kan, Tsai, Chris, Peng, Ching-Tien, Wu, Kang-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471031/ https://www.ncbi.nlm.nih.gov/pubmed/23093863 http://dx.doi.org/10.1155/2012/759503 |
Ejemplares similares
-
An Increase in CD3+CD4+CD25+ Regulatory T Cells after Administration of Umbilical Cord-Derived Mesenchymal Stem Cells during Sepsis
por: Chao, Yu-Hua, et al.
Publicado: (2014) -
Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
por: Chaudhury, Sonali, et al.
Publicado: (2019) -
Characteristics of hematopoietic stem cells of umbilical cord blood
por: Hordyjewska, Anna, et al.
Publicado: (2014) -
Changes of serum aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis
por: Weng, Te-Fu, et al.
Publicado: (2016) -
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation
por: Wang, Hao, et al.
Publicado: (2023)